Cargando…
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
BACKGROUND: Metastatic uveal melanoma is a highly fatal disease; most patients die from their hepatic metastasis within 1 year. A major drawback in the development of new treatments for metastatic uveal melanoma is the difficulty in obtaining appropriate cell lines and the lack of appropriate animal...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481921/ https://www.ncbi.nlm.nih.gov/pubmed/28645290 http://dx.doi.org/10.1186/s12967-017-1247-z |
_version_ | 1783245483992416256 |
---|---|
author | Kageyama, Ken Ohara, Masahiro Saito, Kengo Ozaki, Shinji Terai, Mizue Mastrangelo, Michael J. Fortina, Paolo Aplin, Andrew E. Sato, Takami |
author_facet | Kageyama, Ken Ohara, Masahiro Saito, Kengo Ozaki, Shinji Terai, Mizue Mastrangelo, Michael J. Fortina, Paolo Aplin, Andrew E. Sato, Takami |
author_sort | Kageyama, Ken |
collection | PubMed |
description | BACKGROUND: Metastatic uveal melanoma is a highly fatal disease; most patients die from their hepatic metastasis within 1 year. A major drawback in the development of new treatments for metastatic uveal melanoma is the difficulty in obtaining appropriate cell lines and the lack of appropriate animal models. Patient-derived xenograft (PDX) tumor models, bearing ectopically implanted tumors at a subcutaneous site, have been developed. However, these ectopically implanted PDX models have obstacles to translational research, including a low engraftment rate, slow tumor growth, and biological changes after multiple passages due to the different microenvironment. To overcome these limitations, we developed a new method to directly transplant biopsy specimens to the liver of immunocompromised mice. RESULTS: By using two metastatic uveal melanoma cell lines, we demonstrated that the liver provides a more suitable microenvironment for tumor growth compared to subcutaneous sites and that surgical orthotopic implantation (SOI) of tumor pieces allows the creation of a liver tumor in immunocompromised mice. Subsequently, 10 of 12 hepatic metastasis specimens from patients were successfully xenografted into the immunocompromised mice (83.3% success rate) using SOI, including 8 of 10 needle biopsy specimens (80%). Additionally, four cryopreserved PDX tumors were re-implanted to new mice and re-establishment of PDX tumors was confirmed in all four mice. The serially passaged xenograft tumors as well as the re-implanted tumors after cryopreservation were similar to the original patient tumors in histologic, genomic, and proteomic expression profiles. CT imaging was effective for detecting and monitoring PDX tumors in the liver of living mice. The expression of Ki67 in original patient tumors was a predictive factor for implanted tumor growth and the success of serial passages in PDX mice. CONCLUSIONS: Surgical orthotopic implantation of hepatic metastasis from uveal melanoma is highly successful in the establishment of orthotopic PDX models, enhancing their practical utility for research applications. By using CT scan, tumor growth can be monitored, which is beneficial to evaluate treatment effects in interventional studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-017-1247-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5481921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54819212017-06-23 Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis Kageyama, Ken Ohara, Masahiro Saito, Kengo Ozaki, Shinji Terai, Mizue Mastrangelo, Michael J. Fortina, Paolo Aplin, Andrew E. Sato, Takami J Transl Med Methodology BACKGROUND: Metastatic uveal melanoma is a highly fatal disease; most patients die from their hepatic metastasis within 1 year. A major drawback in the development of new treatments for metastatic uveal melanoma is the difficulty in obtaining appropriate cell lines and the lack of appropriate animal models. Patient-derived xenograft (PDX) tumor models, bearing ectopically implanted tumors at a subcutaneous site, have been developed. However, these ectopically implanted PDX models have obstacles to translational research, including a low engraftment rate, slow tumor growth, and biological changes after multiple passages due to the different microenvironment. To overcome these limitations, we developed a new method to directly transplant biopsy specimens to the liver of immunocompromised mice. RESULTS: By using two metastatic uveal melanoma cell lines, we demonstrated that the liver provides a more suitable microenvironment for tumor growth compared to subcutaneous sites and that surgical orthotopic implantation (SOI) of tumor pieces allows the creation of a liver tumor in immunocompromised mice. Subsequently, 10 of 12 hepatic metastasis specimens from patients were successfully xenografted into the immunocompromised mice (83.3% success rate) using SOI, including 8 of 10 needle biopsy specimens (80%). Additionally, four cryopreserved PDX tumors were re-implanted to new mice and re-establishment of PDX tumors was confirmed in all four mice. The serially passaged xenograft tumors as well as the re-implanted tumors after cryopreservation were similar to the original patient tumors in histologic, genomic, and proteomic expression profiles. CT imaging was effective for detecting and monitoring PDX tumors in the liver of living mice. The expression of Ki67 in original patient tumors was a predictive factor for implanted tumor growth and the success of serial passages in PDX mice. CONCLUSIONS: Surgical orthotopic implantation of hepatic metastasis from uveal melanoma is highly successful in the establishment of orthotopic PDX models, enhancing their practical utility for research applications. By using CT scan, tumor growth can be monitored, which is beneficial to evaluate treatment effects in interventional studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-017-1247-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-23 /pmc/articles/PMC5481921/ /pubmed/28645290 http://dx.doi.org/10.1186/s12967-017-1247-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Kageyama, Ken Ohara, Masahiro Saito, Kengo Ozaki, Shinji Terai, Mizue Mastrangelo, Michael J. Fortina, Paolo Aplin, Andrew E. Sato, Takami Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
title | Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
title_full | Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
title_fullStr | Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
title_full_unstemmed | Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
title_short | Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
title_sort | establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481921/ https://www.ncbi.nlm.nih.gov/pubmed/28645290 http://dx.doi.org/10.1186/s12967-017-1247-z |
work_keys_str_mv | AT kageyamaken establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT oharamasahiro establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT saitokengo establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT ozakishinji establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT teraimizue establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT mastrangelomichaelj establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT fortinapaolo establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT aplinandrewe establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis AT satotakami establishmentofanorthotopicpatientderivedxenograftmousemodelusinguvealmelanomahepaticmetastasis |